PPT-Agonist-Antagonist discrimination: a pseudo-semantic approach to Molecular Dynamics

Author : mia | Published Date : 2022-06-07

Anna Maria Nardiello 1 Lucia Sessa 12 Jacopo Santoro 1 and Stefano Piotto 12 1 Department of Pharmacy University of Salerno Fisciano 84084 Italy 2 Research

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Agonist-Antagonist discrimination: a pse..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Agonist-Antagonist discrimination: a pseudo-semantic approach to Molecular Dynamics: Transcript


Anna Maria Nardiello 1 Lucia Sessa 12 Jacopo Santoro 1 and Stefano Piotto 12 1 Department of Pharmacy University of Salerno Fisciano 84084 Italy 2 Research Centre for . W. ith much content shamelessly pilfered from Dr. . DeFranco’s. lecture slides on . pharmacogenetics. ….. Jennifer Hu. CoSBBI. , July 12 2013 . A few questions to get us started…. What is pharmacogenomics?. Contact us at: contact.omics@omicsonline.org. OMICS . International . through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International journals have over . FORMATION. Konstantinos Tassis. Collaborators: . Karen Willacy, Harold . Yorke. , Neal Turner (JPL/Caltech) . . . Talayeh. . Hezareh. (. MPIfR. ). University of Crete. The Initial . Denise Chac. 10 October 2014. Immunology. The study of the human immune system . Lymphocytes. B Cells. Membrane bound antibody. Activation: bind to pathogen and triggered by helper T cells. MHC II proteins present antigen peptide on cell surface. Yu-Shan . Lin (YSL). Department of . Chemistry. Tufts . University. Simulate how molecules move. Molecular dynamics simulations. km. hr. v. . (0). = . =. . 100. = 1000 kg. = . −. 7000 N. m. s. 2. W. ith much content shamelessly pilfered from Dr. . DeFranco’s. lecture slides on . pharmacogenetics. ….. Jennifer Hu. CoSBBI. , July 12 2013 . A few questions to get us started…. What is pharmacogenomics?. Lesson 7. Quick Re-cap. What is the anatomical position?. What are 3 examples of types of movement?. What is another term used for Agonist?. Define Agonist or ________?. Define Antagonist. What type of joint is your shoulder?. Distinguished University Professor Lecture. Presented on January 29, 2015 by Paul Erhardt, PhD. UT DUP and Director of the Center for Drug Design and Development (CD3). paul.erhardt@utoledo.edu. 1. Outline. Physics 5403: Computational Physics. Physics. 5403: . Computational. . Physics. - . Chapter. 6: . Molecular. Dynamics. 1. 6.0 Overview. What is molecular dynamics (MD)?. Numerical method for studying many-particle systems such as molecules, clusters, and even macroscopic systems such as gases, liquids and solids . Adapt|Compass. Behavioral Health | SouthRiver Community Health Center. Douglas County Pain Summit, March 21, 2017. Best Practices in . Medication Assisted Treatment . for Opioid Use Disorder. Objectives. Lectures. Drug Mechanisms. Receptor Interactions. Pharmacokinetics. Pharm definitions and drug selectivity. Drug= A chemical substance that interacts with a biological substance to produce a physiological effect. Graded Dose-response Relationships. Agonist . drugs mimic the action of the original endogenous ligand for the receptor (for example, isoproterenol mimics norepinephrine on β1 . receptors . of the heart). The magnitude of the drug effect depends on the drug concentration at the receptor site, which, in turn, is determined by both the dose of drug administered and by the drug’s pharmacokinetic profile, such as rate of absorption, distribution, metabolism, and elimination. Pharmacodynamics. Dennis Paul, Ph.D.. dpaul@lsuhsc.edu. Learning Objectives:. Understand the theoretical basis of drug-receptor interactions.. Understand the determinants and types of responses to drug-receptor interactions.. Graded Dose-response . Relationships:. Agonist drugs mimic the action of the original endogenous ligand for the receptor (for example, isoproterenol mimics norepinephrine on β1 receptors of the heart). .

Download Document

Here is the link to download the presentation.
"Agonist-Antagonist discrimination: a pseudo-semantic approach to Molecular Dynamics"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents